Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAIT: Antithrombin for Thromboprophylaxis in Trauma
NCT05794165Phase 2Enrolling by invitation
- Start
- Sep 2023
- Primary completion
- Apr 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of antithrombin III in venous thromboembolism (VTE). Started Sep 2023; status: enrolling by invitation.
02
Drugs
antithrombin III
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT05794165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05794165.